The University of Sydney

Home >

Closing in on a melanoma cure

Professor Rick Kefford’s early clinical trials of new melanoma drugs that target cell abnormalities represent a leap forward in management of this disease, and could lead to improved quality of life and longer lives for patients.

What matters to you, matters to us.

Join the conversation

Share your thoughts about this topic. Have your say.

Professor Rick Kefford

Director, Westmead Institute for Cancer Research
Co-director of Research, Melanoma Institute of Australia

Find out more

Sydney Medical School
Westmead Institute for Cancer Research
Melanoma Institute Australia
Courses in Medicine and Surgery
Research opportunities in Melanoma research

Support this work

How the
world
voted

View now >

View more
topics that
matter

Browse more topics >

Postgraduate
study

Learn more >